OR WAIT null SECS
December 02, 2015
A strong API market is expected in 2016 despite fewer new drug approvals.
October 13, 2015
Umicore is one of the largest producers of platinum APIs for anti-cancer treatment. We pride ourselves in having decades of experience in platinum group metals chemistry and high potency APIs.
September 08, 2015
A study of recent inspection observations allows for baseline trending and continuous improvement. (The opinions expressed in this article do not necessarily reflect FDA’s position on the matter being discussed.)
August 02, 2015
Potential for improved product quality and cost/time savings is reviving interest in perfusion technology.
August 01, 2015
Ignoring a contract partner’s ability to handle highly potent APIs (HPAPIs) safely may have serious consequences. Drug owners and contract service providers alike must understand the complexities and liabilities involved in working with HPAPIs.
July 07, 2015
Catalent’s licensing of Excelimmune’s antibody combination therapy platform can enable the manufacture of multiple recombinant antibodies in a single batch culture.
July 02, 2015
Biologics exhibit greater variability in stability testing than do small-molecule drugs, and maintaining a stable test environment is crucial.
June 30, 2015
GSK will invest in an additional downstream isolation facility for amoxicillin production in Singapore.
June 25, 2015
Novasep's new antibody drug conjugate facility at its site in Le Mans, France will be commissioned in 2016.